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Abstract 
In  this  paper  we  present  preliminary  results  of  the 
European Community multicountry trial HHH (Home or 
Hospital  in  Heart  Failure),  which  assessed  the 
prevalence  and  persistence  of  nocturnal  breathing 
disorders in mild-to-moderate CHF patients. All subjects 
(465) carried out a baseline respiratory recording in the 
hospital, followed by 12 recordings (one per month) at 
home.  The  latter  were  totally  self-managed  by  the 
patients,  and  data  were  transmitted  to  the  referring 
hospital through telephone lines. We found that 43% of 
the patients had a periodic breathing pattern (PB, waxing 
and waning of ventilation with or without apneas) during 
the night lasting  ≥ 1 hour, and the apnea-hypopnea index 
(AHI) was ≥ 5 events/hour in 51% of them. During the 1-
year  follow-up,  a  PB   ≥  1  hour  and  an  AHI  ≥  5 
events/hour were persistent (i.e., occurred in > 50% of 
the recordings) in 43% and 52% of the patients. These 
findings  confirm  the  high  prevalence  of  nocturnal 
breathing disorders in CHF patients and show that in a 
large proportion of patients they tend to persist over time. 
 
1.  Introduction 
In the last years several studies have highlighted the 
clinical and pathophysiological relevance of sleep-related 
breathing  disorders  in  chronic  heart  failure  (CHF) 
patients, providing evidence that they can have important 
implications  in  terms  of  morbidity,  mortality  and  new 
treatment  strategies  [1-4].  Yet,  the  prevalence  of  the 
phenomenon  has  been  investigated  only  in  a  few small 
studies,  and  it  is  still  not  known  whether  nocturnal 
breathing disorders represent an occasional phenomenon 
or tend to persist over time.  
Polysomnography  is  the  standard  technique  used  to 
perform  sleep  studies  and  evaluate  abnormalities  of 
breathing.  This  technique,  however,  is  expensive, 
technically  demanding  and  not  widely  available.  Home 
telemonitoring  of  a  set  of  relevant  cardiorespiratory 
signals might constitute a potential alternative, provided 
the recording and transmission of respiratory data can be 
carried  out  by  the  patient  without  the  need  of  external 
specialized  support  (nurse  or  technician).  We  have 
explored  this  new  strategy  in  the  multi-center  multi-
country trial HHH (Home or Hospital in Heart failure), a 
European  Community-supported  study  (contract  n° 
QLG4-CT-2001-02424)  aimed,  among  other  goals,  at 
evaluating  a  new  system  for  long-term  home 
telemonitoring  of  cardiorespiratory  signals,  which  is 
totally  self-managed  by  the  patient.  The  study  ended 
successfully  on  July  2005,  providing  relevant  data  to 
assess  both  the  prevalence and persistence of nocturnal 
breathing disorders in these subjects. Preliminary results 
on these two points are presented in this paper. 
 
2.  Methods 
Subjects and protocol 
The  HHH  study  has  enrolled  465  patients  with 
symptomatic heart failure (NYHA class II-IV), older than 
18  years,  on  optimized  medical  treatment,  with  LVEF 
≤40 % and with at least one episode of decompensation in 
the previous 12 months. Three countries (UK, Italy and 
Poland) and 11 cardiological departments (5 in Italy, 3 in 
UK and 3 in Poland) were involved in the enrolment and 
follow-up (one year) process. 
Subjects  were  randomized  to  two  groups:  i)  usual 
clinical practice and ii) home telemonitoring. Two-third 
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of the second group were further randomized to perform a 
24-hour cardiorespiratory recording once per month, for a 
total of 12 recordings. All 465 patients carried out an in-
hospital baseline cardiorespiratory recording at enrolment 
in the study. 
To record cardiorespiratory signals we used a Holter-
style 24-hour solid-state portable device (Report-24, FM, 
Monza,  Italy).  This  recorder  is  suitable  to  be  easily 
handled  by  the  patient  at  home  since  only  3  ECG 
electrodes are used to pick-up both the ECG signal (single 
lead)  and  the  respiratory  signal  (bio-impedance 
technique),  while  a  small  plastic  box  houses  the  body 
movement  and  position  sensors  (figure  1).  Sampling 
frequency was 250 Hz for ECG, 10 Hz for respiration and 
1 Hz for the movement and position signals. 
 
 
Fig. 1. Picture of the 24-hour cardiorespiratory recorder 
used in the study (Report-24, FM, Monza, Italy). 
 
After  completion  of  the  24-hour  recording,  the 
recorder is connected by the patient to a dedicated modem 
(Smart  Modem,  Appel  Elettronica,  Torino,  Italy).  Data 
downloading  from  the  recorder  to  the  Smart  Modem’s 
memory buffer and data up-loading from the modem to 
the  receiving  station  starts  automatically  after  the 
connection.  The  overall  transmission,  including  dialing, 
sending  the  patient  ID  and  managing  all  transmission 
problems,  is  automatically  carried  out  by  the  modem 
without the need of patient intervention. 
Signal analysis 
During  the  study,  all  received  recordings  were 
carefully checked by a signal analyst (one per country), 
and a request for repetition was issued to the patient in 
case the poor signal quality.  
Respiratory  recordings  were  analyzed  using  a 
dedicated software package developed for the study. This 
software preprocesses the raw respiratory signal to filter 
out  non-respiratory  frequency  components  and  remove 
sudden changes in signal level or occasional spikes. Then 
an  instantaneous  tidal volume signal is derived and the 
respiratory pattern is classified in each consecutive 60 s 
segment. The classification includes i) “phasic activity”, 
namely  a  breathing  activity  characterized  by  a  regular 
phasic  oscillation  of  respiration  with  or  without 
occasional apneas/hypopneas, and ii) “periodic breathing” 
(PB),  defined  as  a  sustained  oscillation  (≥  3  min, 
modulation  depth  ≥  25%,)  of  ventilatory  amplitude 
characterized by recurring cycles of hyperventilation and 
hypopnea  or  apnea.  Respiratory  segments  with  poor 
signal quality were labeled as “not classified” and were 
excluded from analysis.  
For  the  detection  and  estimation  of  hypopneas  and 
apneas,  we  followed  standard  criteria  used  in 
polysomnography.  Accordingly,  an  hypopnea  (apnea) 
event was defined as a decrease of the instantaneous tidal 
volume below 50% (10%) of the running tidal volume for 
more than 10 sec.  
An interactive procedure allowed the analyst to edit the 
output  of  the  automatic  procedure  in  order  to  correct 
misclassifications  and  adjust  the  duration  of  respiratory 
events.  At  the  end  of  this  interactive  phase,  a  set  of 
standard  and  non  standard  quantitative  indexes  of 
breathing  disorders  was  automatically  provided  by  the 
software, including: i) the duration of PB, ii) the apnea 
index (AI, number of apneas per hour of recording), iii) 
the apnea-hypopnea index (AHI, number of apneas and 
hypopneas  per  hour  of  recording),  and  iv)  the  apnea 
prevalence  (proportion  of  time  spent  in  the  apnea 
condition).  These  parameters  were  computed  for  the 
whole  24-hour  period,  and  for  day-time  and  night-time 
separately. Night-time was defined as the time while the 
patient was lying in bed, as indicated by the body position 
signal, starting from 10.00 p.m. till 8.00 a.m.. 
By convention, a respiratory recording was considered 
eligible  for  the  study  if  the  overall  duration  of  good 
quality signal (i.e., all segments classified as PB or phasic 
activity)  during  night-time  was  ≥  2.5  hours.  Only  data 
from  eligible  recordings  was  entered  in  the  study 
database. 
In  order  to  identify  the  patients  with  nocturnal 
breathing  disorders  we  used  different  parameters  and 
thresholds. In this preliminary report we present results 
according to the following classifications: i) overall PB 
duration ≥ 1 hour, ii) AHI ≥ 5 events /hour, and iii) AHI ≥ 
10 events /hour. 
A given breathing disorder was defined as “persistent” 
if it occurred in > 50% of follow-up recordings, while it 
was defined as “absent” if it did not occur in any follow-
up recording. Breathing disorders not satisfying these two 
criteria  were  defined  as  “occasional”.  The  persistence 
study  was  carried  out  only  in  those  patients  who 
completed  the  follow-up  and  had  ≥  75%  of  home 
recordings eligible. 
Descriptive statistics are given as mean±SD  
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3.  Results 
Prevalence of breathing disorders  
Baseline  recordings  were  eligible  in  399  patients. 
Prevalence results according to the defined criteria for the 
presence of breathing disorders, are given in table 1. It 
can  be  seen  that,  depending  on  the  criterion  used, 
nocturnal breathing disorders affected from one third to 
more than half of the considered population. 
 
Table  1.  Prevalence  of  nocturnal  breathing  disorders 
(from baseline recordings, N=399) 
PB duration 
≥ 1 hour 
AHI 
≥ 5 events/hour 
AHI 
 ≥ 10 events/hour 
43 %  51 %  32 % 
 
The same results are given in table 2 separately for the 
3 countries involved in the study. This table clearly shows 
that the prevalence of nocturnal breathing disorders was 
quite homogeneous among different countries.  
 
Table  2.  Prevalence  of  nocturnal  breathing  in  the  3 
countries of the study (from baseline recordings) 
  PB duration 
≥ 1 hour 
AHI ≥ 5 
events/hour 
AHI  ≥ 10 
events/hour 
Italy  42 %  58 %  37 % 
Poland   43 %  43 %  28 % 
UK  49 %  53 %  28 % 
 
Feasibility of home recordings  
Out of 1689 cardiorespiratory recordings expected to 
be carried out by the patients at home (being the patient 
alive,  not  hospitalized or not dropped out), 89 % were 
actually  performed.  Major  reasons  for  not  performing 
were i) refusal (64%) and ii) organizational problems (29 
%).  Almost  all  (99%)  carried  out  recordings  were 
received  by  the  analysts  located  in  the  country 
coordinating  centers,  and  about  10%  of  them  (N=152) 
had  to  be  repeated  due  to  poor  signal  quality.  In  most 
cases (87 %) only one repetition was carried out. Out of 
1488 recordings available for analysis, 87 % were eligible 
for  the  study.  Therefore,  the  feasibility  of  home 
respiratory recording, namely the proportion of expected 
recordings that were actually carried out and transmitted 
by the patient and were eligible for the study, was 77 %, 
ranging  from  70  %  in  Poland  to  82  %  in  Italy.  The 
average  analyzed  time  during  the  night  was  6.1  ±  1.6 
hours.  
Persistence of nocturnal breathing disorders 
The  strict  requirements  for  the  assessment  of  the 
persistence  of  nocturnal  breathing  disorders  (see 
methods)  were  fulfilled  by  75  patients.  Representative 
examples  of  persistent,  absent  and  not  persistent 
breathing disorder are given respectively in fig.2 a, b, c.  
       (a) 
      (b) 
      (c) 
Fig. 2. Representative examples of persistent (a), absent 
(b) and occasional (c) breathing disorder according to the 
criterion of total periodic breathing (PB) duration during 
the night ≥ 1 hour 
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Global results are reported in table 3. It can be seen 
that in a great proportion of patients nocturnal breathing 
disorders persistently occurred during the overall follow-
up (first row of the table), while in only a minority they 
were  permanently  absent  (second  row  of  the  table).  In 
about one third of the patients breathing disorders were 
only occasional (third row of the table).  
 
Table 3. Persistence of breathing disorders during the 1-
year follow-up according to 3 different criteria.  
  PB duration 
≥ 1 hour 
AHI ≥ 5 
events/hour 
AHI  ≥ 10 
events/hour 
Persistent  43 %  52 %  31 % 
Absent  23 %  16 %  37 % 
Occasional  34 %  32 %  32 % 
 
 
4.  Discussion and conclusions 
These preliminary results from the HHH trial clearly 
show that intermittent long-term home telemonitoring of 
breathing activity based on self-management of recording 
and transmitting devices is feasible in CHF patients and 
their compliance is very high. Using this telemonitoring 
system  we  have  collected  a  great  amount  of  valuable 
information  on  the  prevalence  and  time  course  of 
breathing disorders in these patients, that would not have 
been possible using traditional polysomnography due to 
logistic and cost limitations. The key factors determining 
these  achievements  were  a  suitable  design  of  the 
recording  and  transmitting  devices,  which  properly 
balanced accuracy with usability, and a proper training of 
the patients on the use of telemonitoring devices.  
Our  findings  unambiguously  confirm  the  high 
prevalence  of  nocturnal  breathing  disorders  in  CHF 
patients  and,  for  the  first  time,  provide  relevant 
epidemiological data on the peculiar oscillatory aspect of 
these disorders, namely periodic breathing. 
A  novel  and  relevant  finding  of  this  study  is  that 
nocturnal  breathing  disorders,  when  present,  tend  to 
persist  over  long  periods  of  time  (one  year)  in  a  great 
proportion of patients. This has important implications in 
the clinical management of this patients and may prompt 
towards more aggressive treatments.  
Comparing our results on the prevalence of breathing 
disorders  with  those few available in literature [5-7], it 
appears  that  our  figures  of  AHI  are  lower  than  those 
previously  found  by  other  investigators  using  standard 
polysomnography.  Besides  differences  in  clinical 
characteristics  of  studied  populations  and  in 
inclusion/exclusion  criteria,  one  major  cause  of  this 
discrepancy is likely the different procedure we used to 
compute this index. Indeed, the standard measurement of 
AHI entails dividing the number of breathing events by 
the total sleep time, whereas we divided the number of 
events by the length of the overall analyzed time, roughly 
corresponding to the total time in bed, which, of course, is 
much  greater.  According  to  a  previous  study,  the  ratio 
between total sleep time and total time in bed is around 
0.7. Correcting our prevalence figures by this factor, we 
get  73%  and  46%  for,  respectively,  an  AHI  ≥  5 
events/hour and AHI ≥ 10 events/hour, which are close to 
published data. 
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